More importantly, DDIT4 is described as an independent indicator for a poor prognosis in several malignancies [34], such as acute myeloid leukemia, breast cancer, glioblastoma multiforme, colon, skin and lung cancer. Here, DDIT4 is linked to breast carcinoma.